scholarly article | Q13442814 |
review article | Q7318358 |
P2093 | author name string | Hewlett EL | |
Weiss AA | |||
P921 | main subject | Bordetella pertussis | Q137103 |
P304 | page(s) | 661-686 | |
P577 | publication date | 1986-01-01 | |
P1433 | published in | Annual Review of Microbiology | Q15762942 |
P1476 | title | Virulence factors of Bordetella pertussis. | |
P478 | volume | 40 |
Q67916456 | 12 Purification and assay of cell-invasive form of calmodulin-sensitive adenylyl cyclase from Bordetella pertussis |
Q35414871 | A mutant pertussis toxin molecule that lacks ADP-ribosyltransferase activity, PT-9K/129G, is an effective mucosal adjuvant for intranasally delivered proteins |
Q36986659 | A new assay for invasion of HeLa 229 cells by Bordetella pertussis: effects of inhibitors, phenotypic modulation, and genetic alterations |
Q29615324 | A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR |
Q36123149 | A phase variant of Bordetella pertussis with a mutation in a new locus involved in the regulation of pertussis toxin and adenylate cyclase toxin expression |
Q36114904 | A squid that glows in the night: development of an animal-bacterial mutualism |
Q36958079 | A vir-repressed gene of Bordetella pertussis is required for virulence |
Q37007498 | Activities of complete and truncated forms of pertussis toxin subunits S1 and S2 synthesized by Escherichia coli |
Q41012029 | Adenylate Cyclase Toxin promotes bacterial internalisation into non phagocytic cells. |
Q36578698 | Adhesion of Bordetella pertussis to eukaryotic cells requires a time-dependent export and maturation of filamentous hemagglutinin |
Q38136802 | Adolescents and vaccines in the western world |
Q36184454 | Analysis of Bordetella pertussis virulence gene regulation by use of transcriptional fusions in Escherichia coli |
Q38345586 | Anti-invasive activities of experimental chemotherapeutic agents |
Q46321412 | Antibody response to Bordetella pertussis antigens after immunization with American and Canadian whole-cell vaccines |
Q32018350 | Antigenic analysis of Bordetella pertussis filamentous hemagglutinin with phage display libraries and rabbit anti-filamentous hemagglutinin polyclonal antibodies |
Q40787846 | Antigenic analysis of the saccharide moiety of the lipooligosaccharide of Bordetella pertussis |
Q24563958 | Autophosphorylation and phosphotransfer in the Bordetella pertussis BvgAS signal transduction cascade |
Q35112080 | Biological activities and chemical composition of purified tracheal cytotoxin of Bordetella pertussis |
Q41669187 | Block V RTX Domain of Adenylate Cyclase from Bordetella pertussis: A Conformationally Dynamic Scaffold for Protein Engineering Applications. |
Q39573534 | Bordetella avium virulence measured in vivo and in vitro. |
Q42802062 | Bordetella pertussis adenylate cyclase inactivation by the host cell |
Q73285691 | Bordetella pertussis adenylate cyclase toxin as a tool to analyze molecular interactions in a bacterial two-hybrid system |
Q73089772 | Bordetella pertussis adenylate cyclase toxin: a vehicle to deliver CD8-positive T-cell epitopes into antigen-presenting cells |
Q40429004 | Bordetella pertussis adenylate cyclase toxin: intoxication of host cells by bacterial invasion |
Q40819207 | Bordetella pertussis adenylate cyclase: purification and characterization of the toxic form of the enzyme |
Q36363899 | Bordetella pertussis filamentous hemagglutinin interacts with a leukocyte signal transduction complex and stimulates bacterial adherence to monocyte CR3 (CD11b/CD18). |
Q36975158 | Bordetella pertussis filamentous hemagglutinin: evaluation as a protective antigen and colonization factor in a mouse respiratory infection model |
Q40146679 | Bordetella pertussis induces respiratory burst activity in human polymorphonuclear leukocytes |
Q35598411 | BvgAS is sufficient for activation of the Bordetella pertussis ptx locus in Escherichia coli |
Q34533729 | BvgAS-mediated signal transduction: analysis of phase-locked regulatory mutants of Bordetella bronchiseptica in a rabbit model |
Q34388681 | Calcium-induced folding and stabilization of the intrinsically disordered RTX domain of the CyaA toxin |
Q34522858 | Cell-mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model |
Q46797483 | Central role of the BvgS receiver as a phosphorylated intermediate in a complex two-component phosphorelay |
Q34525735 | Characterization of environmental regulators of Bordetella pertussis. |
Q36980977 | Characterization of genetically inactivated pertussis toxin mutants: candidates for a new vaccine against whooping cough |
Q67710978 | Characterization of monoclonal antibodies directed against domains of pertussis toxin involved in receptor recognition |
Q34530115 | Characterization of murine lung inflammation after infection with parental Bordetella pertussis and mutants deficient in adhesins or toxins. |
Q33727319 | Characterization of the bvgR locus of Bordetella pertussis |
Q35531701 | Characterization of the fim2 and fim3 fimbrial subunit genes of Bordetella bronchiseptica: roles of Fim2 and Fim3 fimbriae and flagella in adhesion. |
Q36526152 | Charge-dependent translocation of Bordetella pertussis adenylate cyclase toxin into eukaryotic cells: implication for the in vivo delivery of CD8(+) T cell epitopes into antigen-presenting cells. |
Q39845099 | Cloning and characterization of an Mn-containing superoxide dismutase (SodA) of Bordetella pertussis |
Q36697551 | Cloning and characterization of btr, a Bordetella pertussis gene encoding an FNR-like transcriptional regulator |
Q33322543 | Cloning of the recA gene of Bordetella pertussis and characterization of its product |
Q35524244 | Cloning, expression, and molecular characterization of the dermonecrotic toxin gene of Bordetella spp |
Q41534891 | Common accessory genes for the Bordetella pertussis filamentous hemagglutinin and fimbriae share sequence similarities with the papC and papD gene families |
Q37055410 | Common themes in microbial pathogenicity |
Q36946178 | Comparative roles of the Arg-Gly-Asp sequence present in the Bordetella pertussis adhesins pertactin and filamentous hemagglutinin |
Q35197120 | Complement evasion by Bordetella pertussis: implications for improving current vaccines |
Q54582583 | Conserved sequence motifs in the unorthodox BvgS two-component sensor protein of Bordetella pertussis. |
Q36113182 | Constitutive sensory transduction mutations in the Bordetella pertussis bvgS gene |
Q39891888 | Construction of Bordetella pertussis strains that overproduce genetically inactivated pertussis toxin |
Q35951021 | Construction of Bordetella pertussis strains with enhanced production of genetically-inactivated Pertussis Toxin and Pertactin by unmarked allelic exchange |
Q36972449 | Construction of a diphtheria toxin A fragment-C180 peptide fusion protein which elicits a neutralizing antibody response against diphtheria toxin and pertussis toxin |
Q33762528 | Contribution of regulation by the bvg locus to respiratory infection of mice by Bordetella pertussis. |
Q35105715 | Deletions affecting hemolytic and toxin activities of Bordetella pertussis adenylate cyclase |
Q36997301 | Dermonecrotic toxin and tracheal cytotoxin, putative virulence factors of Bordetella avium |
Q37121285 | Detection of antibodies inhibiting the ADP-ribosyltransferase activity of pertussis toxin in human serum |
Q36117132 | Development and clinical testing of an acellular pertussis vaccine containing genetically detoxified pertussis toxin |
Q37162144 | Development of a rapid diagnostic test for pertussis: direct detection of pertussis toxin in respiratory secretions |
Q40426607 | Development of a rat model for respiratory infection with Bordetella pertussis |
Q39654926 | DsbA and DsbC are required for secretion of pertussis toxin by Bordetella pertussis |
Q69664373 | Dual effects of pertussis toxin on in vitro invasive behavior of metastatic lymphoma variants |
Q37024321 | Effect of immunization on experimental Bacteroides gingivalis infection in a murine model |
Q41812746 | Effect of increased CRM₁₉₇ carrier protein dose on meningococcal C bactericidal antibody response |
Q73544795 | Effect of pertussis toxin on the induction of nitric oxide synthesis in murine macrophages and on protection in vivo |
Q24645085 | Effects of Bordetella pertussis infection on human respiratory epithelium in vivo and in vitro |
Q37006688 | Effects of mutations on enzyme activity and immunoreactivity of the S1 subunit of pertussis toxin |
Q35109791 | Effects of recombinant human interleukin-1 beta on accumulation of inflammatory peritoneal macrophages in mice treated with pertussis toxin. |
Q35489176 | Endogenous synthesis of peptidoglycan in eukaryotic cells; a novel concept involving its essential role in cell division, tumor formation and the biological clock |
Q36184411 | Environmental regulation of expression of virulence determinants in Bordetella pertussis |
Q40895493 | Environmental regulation of virulence factors in Bordetella species |
Q33951468 | Environmental sensing mechanisms in Bordetella |
Q30311283 | Enzymatic activity of adenylate cyclase toxin from Bordetella pertussis is not required for hemolysis. |
Q40374672 | Epithelial cell invasion and survival of Bordetella bronchiseptica |
Q30303946 | Epitope mapping of monoclonal antibodies against Bordetella pertussis adenylate cyclase toxin |
Q30451064 | Evaluation of the mouse model for study of encephalopathy in pertussis vaccine recipients |
Q35524357 | Expression and immunogenicity of pertussis toxin S1 subunit-tetanus toxin fragment C fusions in Salmonella typhi vaccine strain CVD 908 |
Q36180719 | Expression and secretion of the S-1 subunit and C180 peptide of pertussis toxin in Escherichia coli |
Q54465346 | Expression of a pertussis toxin S1 fragment by inducible promoters in oral Streptococcus and the induction of immune responses during oral colonization in mice. |
Q40426961 | Expression of pertussis toxin in Bordetella bronchiseptica and Bordetella parapertussis carrying recombinant plasmids |
Q38291883 | Filamentous hemagglutinin of Bordetella pertussis: a key adhesin with immunomodulatory properties? |
Q33849955 | Filamentous hemagglutinin of Bordetella pertussis: nucleotide sequence and crucial role in adherence |
Q33921411 | Fimbrial phase variation in Bordetella pertussis: a novel mechanism for transcriptional regulation |
Q36101480 | Flagellin gene transcription in Bordetella bronchiseptica is regulated by the BvgAS virulence control system |
Q73522244 | Flagellin, a major protein present in SDS-PAGE profiles of Sarkosyl-OMP-enriched fractions from Bordetella bronchiseptica Bvg- or modulated Bvg+ strains |
Q35125420 | Fungal virulence genes as targets for antifungal chemotherapy. |
Q72153337 | Global regulatory mechanisms affect virulence gene expression in Bordetella pertussis |
Q33936210 | Gram-negative bacterial protein secretion |
Q30451204 | Heparin-inhibitable lectin activity of the filamentous hemagglutinin adhesin of Bordetella pertussis |
Q77488404 | Human but not ovine isolates of Bordetella parapertussis are highly clonal as determined by PCR-based RAPD fingerprinting |
Q39841503 | Identification and characterization of BpH2, a novel histone H1 homolog in Bordetella pertussis. |
Q67690195 | Identification and characterization of a protective immunodominant B cell epitope of pertactin (P.69) fromBordetella pertussis |
Q33599636 | Identification of B-cell epitopes on the S4 subunit of pertussis toxin |
Q42824590 | Identification of Glu173 as the critical amino acid residue for the ADP‐ribosyltransferase activity of Clostridium botulinum C3 exoenzyme |
Q36976504 | Identification of a 68-kilodalton outer membrane protein as the major protective antigen of Bordetella bronchiseptica by using specific-pathogen-free piglets |
Q35579097 | Identification of a Bordetella pertussis bvg-regulated porin-like protein |
Q35589375 | Identification of a Bordetella pertussis regulatory factor required for transcription of the pertussis toxin operon in Escherichia coli |
Q24673257 | Identification of a locus required for the regulation of bvg-repressed genes in Bordetella pertussis |
Q33584398 | Identification of a region in the S1 subunit of pertussis toxin that is required for enzymatic activity and that contributes to the formation of a neutralizing antigenic determinant |
Q39412993 | Identification of a region that assists membrane insertion and translocation of the catalytic domain of Bordetella pertussis CyaA toxin. |
Q33852277 | Identification of amino acid residues essential for the enzymatic activities of pertussis toxin |
Q36951337 | Identification of human T-cell epitopes on the S4 subunit of pertussis toxin |
Q36962237 | Identification of linear B-cell determinants of pertussis toxin associated with the receptor recognition site of the S3 subunit. |
Q34520581 | Identification of murine T-cell epitopes on the S4 subunit of pertussis toxin |
Q33562083 | Identification of residues essential for catalysis and binding of calmodulin in Bordetella pertussis adenylate cyclase by site-directed mutagenesis |
Q40151896 | Identification of subregions of Bordetella pertussis filamentous hemagglutinin that stimulate human T-cell responses |
Q35440977 | Identification of two bvg-repressed surface proteins of Bordetella pertussis. |
Q36947250 | Immunological characterization of the lipooligosaccharide B band of Bordetella pertussis |
Q51619806 | Influence of Culture Conditions on Expression of Antigens in Bordetella bronchiseptica |
Q37007066 | Inhibition of pertussis toxin binding to model receptors by antipeptide antibodies directed at an antigenic domain of the S2 subunit |
Q38330594 | Insertional mutagenesis of Bordetella pertussis adenylate cyclase |
Q35844973 | Integration of multiple domains in a two-component sensor protein: the Bordetella pertussis BvgAS phosphorelay |
Q41730558 | Invasive adenylyl cyclase of Bordetella pertussis. Physical, catalytic, and toxic properties |
Q38347519 | Lectin-like binding of pertussis toxin to a 165-kilodalton Chinese hamster ovary cell glycoprotein |
Q37006917 | Lethal infection by Bordetella pertussis mutants in the infant mouse model. |
Q48343966 | Localisation of a receptor‐recognition domain on the S3 subunit of pertussis toxin by peptide mapping |
Q35225640 | Long-term human serum antibody responses after immunization with whole-cell pertussis vaccine in France |
Q35090392 | Mapping of linear B-cell epitopes of the S2 subunit of pertussis toxin. |
Q90271081 | Membrane Activity and Channel Formation of the Adenylate Cyclase Toxin (CyaA) of Bordetella pertussis in Lipid Bilayer Membranes |
Q30464914 | Membrane depolarization prevents cell invasion by Bordetella pertussis adenylate cyclase toxin |
Q47128421 | Membrane-Active Properties of an Amphitropic Peptide from the CyaA Toxin Translocation Region |
Q89736265 | Microbiome-Guided Exploration of the Microbial Assemblage of the Exotic Beverage "Insect Tea" Native to Southwestern China |
Q33856363 | Molecular cloning and characterization of protective outer membrane protein P.69 from Bordetella pertussis |
Q41136315 | Molecular mechanisms of action of bacterial exotoxins. |
Q24522458 | Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies |
Q35101534 | Monoclonal antibodies that define neutralizing epitopes of pertussis toxin: conformational dependence and epitope mapping |
Q36978289 | Monoclonal antibodies that inhibit ADP-ribosyltransferase but not NAD-glycohydrolase activity of pertussis toxin |
Q34856100 | Mucosal immunization with a genetically engineered pertussis toxin S1 fragment-cholera toxin subunit B chimeric protein |
Q36159607 | Mutagenesis of Bordetella pertussis with transposon Tn5tac1: conditional expression of virulence-associated genes |
Q39514520 | Mutations in the S1 subunit of pertussis toxin that affect secretion |
Q36955465 | Non-O1 Vibrio cholerae NRT36S produces a polysaccharide capsule that determines colony morphology, serum resistance, and virulence in mice |
Q47687598 | Novel molecular biology approaches to acellular vaccines. |
Q40408438 | Nucleotide sequences of the 23S rRNA genes fromBordetella pertussis, B.parapertussis, B.bronchisepticaandB.avium, and their implications for phylogenetic analysis |
Q37367187 | Pertactin, an Arg-Gly-Asp-containing Bordetella pertussis surface protein that promotes adherence of mammalian cells |
Q30406104 | Pertussis pathogenesis--what we know and what we don't know |
Q35106128 | Pertussis toxin analog with reduced enzymatic and biological activities is a protective immunogen |
Q33849682 | Pertussis toxin induces structural changes in G alpha proteins independently of ADP-ribosylation |
Q36633486 | Pertussis: the disease and new diagnostic methods |
Q39517446 | Phagosome acidification has opposite effects on intracellular survival of Bordetella pertussis and B. bronchiseptica |
Q35553903 | Phase variation affects long-term survival of Bordetella bronchiseptica in professional phagocytes |
Q37006249 | Photolabeling of Glu-129 of the S-1 subunit of pertussis toxin with NAD. |
Q68703297 | Pneumonia in mice produced by cell-free extract of cultures of Bordetella parapertussis |
Q33770898 | Positive transcriptional feedback at the bvg locus controls expression of virulence factors in Bordetella pertussis |
Q44601288 | Preliminary X-ray crystallographic analysis of holotoxin from Bordetella pertussis |
Q55614614 | Progress with a recombinant whooping cough vaccine: a review. |
Q34007024 | Proinflammatory and proapoptotic activities associated with Bordetella pertussis filamentous hemagglutinin |
Q36945908 | Properties of pertussis toxin B oligomer assembled in vitro from recombinant polypeptides produced by Escherichia coli |
Q37194900 | Pseudomonas fluorescens Filamentous Hemagglutinin, an Iron-Regulated Protein, Is an Important Virulence Factor that Modulates Bacterial Pathogenicity |
Q24672139 | Repressor binding to a regulatory site in the DNA coding sequence is sufficient to confer transcriptional regulation of the vir-repressed genes (vrg genes) in Bordetella pertussis |
Q39519875 | Reversal of the CD4(+)/CD8(+) T-cell ratio in lymph node cells upon in vitro mitogenic stimulation by highly purified, water-soluble S3-S4 dimer of pertussis toxin |
Q34003893 | Role of Bordetella bronchiseptica fimbriae in tracheal colonization and development of a humoral immune response |
Q35997289 | Secretion of cyclolysin, the calmodulin-sensitive adenylate cyclase-haemolysin bifunctional protein of Bordetella pertussis |
Q34301295 | Sequences required for expression of Bordetella pertussis virulence factors share homology with prokaryotic signal transduction proteins |
Q68483852 | Simultaneous determination of Bordetella pertussis toxin and filamentous haemagglutinin concentrations by hydroxyapatite high-performance liquid chromatography |
Q36361184 | Site-specific alterations in the B oligomer that affect receptor-binding activities and mitogenicity of pertussis toxin |
Q40156064 | Site-specific mutagenesis of the catalytic subunit of cholera toxin: substituting lysine for arginine 7 causes loss of activity |
Q37523902 | Strain-dependent role of BrkA during Bordetella pertussis infection of the murine respiratory tract |
Q54466575 | Structural and functional characterization of an essential RTX subdomain of Bordetella pertussis adenylate cyclase toxin. |
Q34000750 | Surface expression of a protective recombinant pertussis toxin S1 subunit fragment in Streptococcus gordonii. |
Q34540112 | Surface-associated filamentous hemagglutinin induces autoagglutination of Bordetella pertussis |
Q36980641 | Synthesis and secretion of Bordetella pertussis adenylate cyclase as a 200-kilodalton protein |
Q59632332 | Th1/Th2 cell dichotomy in acquired immunity to Bordetella pertussis: variables in the in vivo priming and in vitro cytokine detection techniques affect the classification of T-cell subsets as Th1, Th2 or Th0 |
Q38307893 | The 70-kilodalton pertussis toxin-binding protein in Jurkat cells. |
Q91962664 | The ADP-Ribosylating Toxins of Salmonella |
Q60364407 | The Conserved Lysine 860 in the Additional Fatty-acylation Site ofBordetella pertussisAdenylate Cyclase Is Crucial for Toxin Function Independently of Its Acylation Status |
Q24684499 | The bvgAS locus negatively controls motility and synthesis of flagella in Bordetella bronchiseptica |
Q34058617 | The family of bacterial ADP-ribosylating exotoxins |
Q39573830 | The lipopolysaccharide of Bordetella bronchiseptica acts as a protective shield against antimicrobial peptides. |
Q24515340 | The past, present, and future of pertussis. The role of adults in epidemiology and future control |
Q64451175 | The pathogenesis and immunology of Vibrio cholerae and Bordetella pertussis |
Q50201335 | The primary and secondary cellular immune responses to whole cell Bordetella pertussis vaccine and its components |
Q79754576 | The rise in pertussis cases urges replacement of chemically-inactivated with genetically-inactivated toxoid for DTP |
Q36170267 | The role of the acellular pertussis vaccine and the demise of 'Pertussis Pete'. |
Q30307945 | Translocation-specific conformation of adenylate cyclase toxin from Bordetella pertussis inhibits toxin-mediated hemolysis |
Q36221230 | Two trans-acting regulatory genes (vir and mod) control antigenic modulation in Bordetella pertussis |
Q33559645 | Type V protein secretion pathway: the autotransporter story |
Q40152070 | Uptake and intracellular survival of Bordetella pertussis in human macrophages |
Q33759996 | Vag8, a Bordetella pertussis bvg-regulated protein. |
Q42604835 | Vir90, a virulence-activated gene coding for a Bordetella pertussis iron-regulated outer membrane protein |
Q33919168 | Virulence dependent and independent regulation of the Bordetella pertussis cya operon |
Q64451161 | Virulence factors of Bordetella pertussis |
Q37420816 | Virulence, immunity, and vaccine related to Streptococcus pneumoniae |
Search more.